Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Shi

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moietyYun-Long Li, Eric Shi, David Burns, et al.
Oncotarget|February 9, 2018
Iodine stimulates estrogen receptor singling and its systemic level is increased in surgical patients due to topical absorptionShaohua He, Bingchan Wang, Xiyi Lu, et al.
International Journal of Cancer|May 31, 2007
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancerJianping Guo, Chengchao Shou, Lin Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growthYingJun Zhou, Yiliang Ellie Liu, JianGuo Cao, et al.
Medical Oncology (Northwood, London, England)|May 23, 2013
Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancerKejin Wu, Shuo Huang, Mingjie Zhu, et al.
Journal of Pharmaceutical Sciences|June 24, 2025
Strategies for the evaluation and characterization of higher-order structures, supramolecular higher-order structures, and aggregates in oligonucleotide therapeuticsLaure-Elie Carloni, George Bou-Assaf, Arani Chanda, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approachColin Zhang, Meizhong Xu, Chunhong He, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moietyYun-Long Li, Eric Shi, David Burns, et al.
Oncotarget|February 9, 2018
Iodine stimulates estrogen receptor singling and its systemic level is increased in surgical patients due to topical absorptionShaohua He, Bingchan Wang, Xiyi Lu, et al.
International Journal of Cancer|May 31, 2007
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancerJianping Guo, Chengchao Shou, Lin Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growthYingJun Zhou, Yiliang Ellie Liu, JianGuo Cao, et al.
Medical Oncology (Northwood, London, England)|May 23, 2013
Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancerKejin Wu, Shuo Huang, Mingjie Zhu, et al.
Journal of Pharmaceutical Sciences|June 24, 2025
Strategies for the evaluation and characterization of higher-order structures, supramolecular higher-order structures, and aggregates in oligonucleotide therapeuticsLaure-Elie Carloni, George Bou-Assaf, Arani Chanda, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2007
Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWenqing Yao, Jincong Zhuo, David M Burns, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2022
Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approachColin Zhang, Meizhong Xu, Chunhong He, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Pageof 5